Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06277882

Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis

Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis: A Randomized-controlled Trial

Sponsor: Mahidol University

Conditions Cirrhosis Hep A Vaccination

Interventions HAVRIX

Updated 4 times since 2024 Last updated: Mar 18, 2024 Started: Feb 29, 2024 Primary completion: Mar 1, 2025 Completion: May 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cirrhosis and Hep A, this trial is actively recruiting participants. The trial is conducted by Mahidol University and has accumulated 4 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Apr 2024 — Jul 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Mar 2024 — Apr 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Feb 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mahidol University

Data source: Mahidol University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok Noi, Thailand